923981-14-0

Basic information

• Product Name: Centanafadine HCl
• Synonyms: Centanafadine HCl
• CAS NO: 923981-14-0
• Molecular Formula: C15H16ClN
• Molecular Weight: 245.74724
• EINECS: -0
• Product Categories: APIS
• Mol File: 923981-14-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Centanafadine HCl(CAS DataBase Reference)
• NIST Chemistry Reference: Centanafadine HCl(923981-14-0)
• EPA Substance Registry System: Centanafadine HCl(923981-14-0)

Safety Data

• Hazardous Substances Data: 923981-14-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Centanafadine HCl is used as a treatment for attention deficit hyperactivity disorder (ADHD) due to its ability to inhibit the reuptake of serotonin, norepinephrine, and dopamine, which are neurotransmitters involved in regulating mood, attention, and impulse control.

Upstream product

• 1004551-75-0 [(1S,2R)-2-(aminomethyl)-2-(2-naphthyl)cyclopropyl]methan-1-ol p-toluenesulfonic acid salt 
• 132-75-2 naphthalen-1-ylacetonitrile 

Relevant articles and documents

NOVEL MANUFACTURING METHOD

PROBLEM TO BE SOLVED: To provide a manufacturing method providing high optical purity, having inexpensive price and easily being handled in industrial manufacturing of a final product material having excellent biological activity. SOLUTION: There is provi

CRYSTALLINE COMPOUNDS

The present invention relates to crystalline forms of (1R,5S)-1-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane hydrochloride and compositions comprising the same and methods of making and using the same.

USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO{3.1.0}HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS

The present invention relates to (lR,5S)-(+)-l-(naphthalen-2-yl)-3-azabicyclo[3.1.0]hexane and pharmaceutical compositions thereof, and methods employing their use in the treatment of conditions affected by monoamine neurotransmitters, including ADHD and

METHODS AND COMPOSITIONS FOR PRODUCTION, FORMULATION AND USE OF 1 ARYL -3-AZABICYCLO[3.1.0 ] HEXANES

The invention provides novel compositions and methods of making (-)-1-(3,4- dichlorophenyl)-3-azabicyclo[3.1.0]hexane and other 1-aryl-3- azabicyclo[3.1.0]hexanes, including synthetic methods that form novel intermediate compounds of the invention for pro

NOVEL 1-ARYL-3-AZABICYCLO[3.1.0]HEXANES: PREPARATION AND USE TO TREAT NEUROPSYCHIATRIC DISORDERS

The invention provides novel, multiply-substituted l-aryl-3-azabicyclo[3.1.0]hexanes, and related processes and intermediates for preparing these compounds, as well as compositions and methods employing these compounds for the treatment and/or prevention of central nervous system (CNS) disorders, including depression and anxiety.